Advertisement

Life Sciences

EPfizer, Ginkgo ink $331M deal | Weight-loss drug market may hit $100B by 2035 | 58 best healthcare employers, per US News | Penn Medicine tests Lyme disease vaccine | Ulcer drug recalled

September 27, 2023 BHR Newsletter 1. Pfizer, Ginkgo ink $331M partnership Full story 2. Top 58 healthcare companies to work for, per US News Full story 3. Weight-loss drug market could reach $100B by 2035 Full story 4. Leaders need to tackle the staffing crisis from all…

Eli Lilly sues spas, clinics over Mounjaro copycat | 3 biotech co. layoffs | J&J rebrands, cuts script logo | How Ascension is paring down amid $3B loss | Ozempic, Wegovy shortages could last years

September 20, 2023 BHR Newsletter 1. Eli Lilly sues spas, clinics over Mounjaro copycats Full story 2. How Ascension is paring down amid $3B loss Full story 3. 3 biotech company layoffs Full story 4. EHR training doesn't have to be a necessary evil. See how Froedtert…

2seventy bio cuts 40% of workforce | Ozempic, Wegovy tested as dementia, addiction drug | Aktiv Pharma Group to shutter operations | The healthcare quality blindspot | 5 updates on Mark Cuban's drug co.

September 13, 2023 BHR Newsletter 1. Biotech company cuts 40% of workforce Full story 2. A blind spot in healthcare quality work Full story 3. Ozempic, Wegovy enter trials for treating addiction, dementia Full story 4. A flexible workforce doesn't require reliance on contract labor. Hospitals are…

Advertisement

Absci lays off 15% of staff | Walgreens CEO steps down | Drugmaker recalls heart drug after dose mix-up | When C-level roles are too big for one person | 1st drug reduces 'sticky' cholesterol by 65%

September 6, 2023 BHR Newsletter 1. Biotech company lays off 15% of staff Full story 2. When C-level roles are too big for one person Full story 3. Walgreens CEO steps down Full story 4. OR improvement efforts are futile without surgeon buy-in. See how this hospital…

CVS launches biosimilar subsidiary | Pfizer eyes reopening NC plant | Fla. hospitals prep for Idalia | Rite Aid to file for bankruptcy | QuantHealth raises $15M | HHS invest $1.4B in new COVID-19 tools

August 30, 2023 BHR Newsletter 1. Pfizer eyes reopening North Carolina plant by Q4 Full story 2. 4 Florida hospitals evacuate, close ahead of Idalia Full story 3. Rite Aid to file for bankruptcy: Report Full story 4. Boost productivity — without the burnout. Register here to…

FDA halts Gilead cancer drug study | Willow taps new biopharma partner | Optum lays off nurses | 10 drugs CMS might tap for negotiations | FDA warns AstraZeneca over false advertising of COPD drug

August 23, 2023 BHR Newsletter 1. FDA pauses enrollment in Gilead cancer drug study Full story 2. All nurses reportedly laid off at more than 100 Optum-owned clinics Full story 3. The 10 drugs that CMS might wrangle into negotiations Full story 4. What's ChatGPT's place in…

FDA halts drug trial after subject's death | Drug co. cuts COO role, to lay off 400 | Top 10 universities for life sciences | Healthcare's widest CEO-worker pay gaps | Novo Nordisk to buy obesity drugmaker for $1B

August 16, 2023 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts  •   MyBHC 1. FDA puts drug trial on hold after subject's death Full story 2. 'It's ridiculous': Why hospitals pay millions to get paid electronically Full story 3. Maryland drug company cuts COO…

Ozempic, Mounjaro stomach paralysis claims led to lawsuit | Amazon zeros in on genomics | Ill. system lays off 20% of leaders | Sage considers job cuts, drug pricing delays

August 9, 2023 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts  •   MyBHC 1. Ozempic, Mounjaro drugmakers sued over stomach paralysis claims Full story 2. Illinois system lays off 20% of leadership Full story 3. Sage ponders cutting jobs, delaying drug pricing after partial…

Advertisement